title: Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke.
abstract: BACKGROUND
  Neuroendocrine changes are important processes which accompany critical illness, however, the number of clinical studies concentrating on the role of thyroid gland hormones in stroke pathogenesis is relatively small. The aim of this prospective study was to investigate the relation between free triiodothyronine (fT3) levels and the prognosis of patients with stroke.
  
  
  METHODS
  The prospective study included 387 patients with acute (<24 h of symptoms onset) ischemic stroke consecutively admitted to Stroke Units. The subjects with known conditions that could interfere with thyroid gland metabolism were excluded. We analyzed: the routine blood tests, fT3, free thyroxine (fT4), thyroid-stimulating hormone (TSH) levels, unenhanced CT scans, initial clinical status (NIH Stroke Scale, NIHSS), 30- and 360- days outcome (modified Rankin Scale-mRS) and calculated the survival rate.
  
  
  RESULTS
  A higher NIHSS score was in the 1 (st) fT3 levels tertile, whereas a lower in the 3 (rd) fT3 levels tertile (p=0.006). The 30- and 360-days mRS scores showed that patients in the lowest fT3 tertile had more severe neurological impairment than those in the highest tertile (p=0.001 and p=0.03, respectively). A 1-year mortality of the patients with the first tertile fT3 levels was significantly higher than that of the patients with the third tertile hormone levels (p=0.008). Additionally, subjects with fT3 level in the lowest tertile demonstrated higher WBC counts and the ventricular system on Computed Tomography of head performed on admission to hospital was statistically more frequent compressed than that in the patients with fT3 level in the highest tertile (p=0.02 and p=0.03, respectively).
  
  
  CONCLUSIONS
  In acute stroke patients lower free T3 levels are an important factor related to unfavorable outcome, i. e., severe disability and death.
authors.affiliation: Biomedical Imaging Lab, Agency for Science Technology and Research, Singapore. wambrosius@amp.edu.pl
authors.forename: W
authors.initials: W
authors.lastname: Ambrosius
authors.forename: R
authors.initials: R
authors.lastname: Kazmierski
authors.forename: V
authors.initials: V
authors.lastname: Gupta
authors.forename: A Wencel
authors.initials: AW
authors.lastname: Warot
authors.forename: D
authors.initials: D
authors.lastname: Adamczewska-Kociałkowska
authors.forename: A
authors.initials: A
authors.lastname: Błazejewska
authors.forename: K
authors.initials: K
authors.lastname: Ziemnicka
authors.forename: W L
authors.initials: WL
authors.lastname: Nowinski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D020521:Stroke / Q000097:blood*; D013972:Thyrotropin / Q000097:blood*; D013974:Thyroxine / Q000097:blood*; D014057:Tomography, X-Ray Computed; D014284:Triiodothyronine / Q000097:blood*
chemical_list: D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine